🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 10 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/03/2025 17,16 17,48 16,57 17,11 -3,39% 5,30% 2.522.400
03/03/2025 18,94 18,97 17,61 17,71 -6,35% 7,18% 1.640.300
28/02/2025 18,77 19,04 18,53 18,91 -0,16% 2,72% 1.220.300
27/02/2025 19,17 19,97 18,91 18,94 -1,51% 5,50% 1.043.200
26/02/2025 19,72 19,98 19,08 19,23 -1,54% 4,56% 1.130.800
25/02/2025 19,05 19,82 18,48 19,53 +3,55% 7,01% 1.651.300
24/02/2025 19,89 19,89 18,59 18,86 -5,23% 6,56% 1.392.400
21/02/2025 21,20 21,31 19,88 19,90 -5,06% 6,75% 1.202.000
20/02/2025 21,08 21,24 20,55 20,96 -0,57% 3,27% 1.306.400
19/02/2025 20,25 21,24 20,25 21,08 +3,13% 4,89% 1.216.400
18/02/2025 20,00 20,76 20,00 20,44 +2,46% 3,80% 1.071.900
14/02/2025 19,27 20,20 19,07 19,95 +4,40% 5,86% 930.600
13/02/2025 18,83 19,21 18,14 19,11 +2,91% 5,68% 1.257.000
12/02/2025 18,35 18,61 17,57 18,57 -1,69% 5,67% 1.904.900
11/02/2025 18,23 19,80 18,23 18,89 -5,17% 8,61% 1.772.900
10/02/2025 20,39 20,48 19,37 19,92 -1,58% 5,44% 1.503.000
07/02/2025 20,56 21,84 20,14 20,24 -1,17% 8,27% 1.415.500
06/02/2025 20,32 20,53 19,95 20,48 +1,04% 2,86% 1.264.700
05/02/2025 19,86 20,53 19,79 20,27 +3,00% 3,73% 1.248.400
04/02/2025 18,70 19,77 18,66 19,68 +5,02% 5,96% 1.092.600
03/02/2025 19,03 19,44 18,55 18,74 -5,73% 4,70% 1.620.100
31/01/2025 20,30 20,50 19,28 19,88 -1,73% 6,03% 1.314.500
30/01/2025 20,15 20,65 19,96 20,23 +1,40% 3,41% 1.451.300
29/01/2025 19,88 20,30 19,69 19,95 -0,40% 3,07% 1.295.900
28/01/2025 20,40 20,64 19,79 20,03 -1,09% 4,15% 1.446.000
27/01/2025 20,75 21,13 19,89 20,25 -2,46% 6,00% 1.664.900
24/01/2025 21,23 21,73 20,37 20,76 -3,58% 6,41% 23.746.300
23/01/2025 20,05 21,67 19,82 21,53 +9,23% 9,23% 3.850.600
22/01/2025 19,71 20,02 19,41 19,71 -0,25% 3,09% 1.008.200
21/01/2025 20,00 20,48 19,57 19,76 +1,02% 4,55% 1.338.200